Trends in mortality of renal failure in adult multiple myeloma patients: a CDC data analysis (1999–2020)

No abstract is available for this paper.

• Publication year

  2025

• Venue

  International Urology and Nephrology

• Publication date

  2025-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-025-04788-5PMID 40936059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What are stem cells?

  2021cited by this paper
• Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

  2018cited by this paper
• Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States.

  2017cited by this paper
• International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.

  2016cited by this paper
• Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group

  2012cited by this paper
• Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.

  2011cited by this paper
• Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.

  2011cited by this paper
• Pathogenesis and treatment of renal failure in multiple myeloma

  2008cited by this paper
• Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

  2002cited by this paper
• Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

  2002cited by this paper

• Multiple Myeloma and Chronic Kidney Disease–Related Mortality, 1999–2023: A Population-Based Time-Trend Analysis

  2025cites this paper